entertainment -WSS

entertainment

author：entertainment 2025-09-30 05:07:50 - browse：45725

Several amyloid plaques forming between neurons in a brain — Amyloid plaques forming between neurons. Adobe

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest.

The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company, and sold in partnership with Biogen. It previously secured conditional approval in January. The FDA’s decision will broaden patient access to the drug under the Medicare program and is likely to boost sales, even as Leqembi’s benefits and safety risks continue to be a source of debate.

Leqembi’s full, or traditional, approval was supported by results of a large clinical trial in which the drug slowed the rate of cognitive and functional decline by 27% compared to a placebo. Leqembi also beat placebo on a series of secondary measures of Alzheimer’s, and it had a dramatic effect on clearing toxic brain plaques called beta-amyloid, which play a role in the progression of the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Wikipedia

WSS

Shionogi licenses Pompe disease therapy from Maze Therapeutics

I learned firsthand about improving diversity in clinical trials

Sanofi strikes deal with Novavax, boosting the vaccine maker

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Study: AI not yet building 'n

Hospitals struggle to profit from CAR

explore

entertainment

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Tesla recalling nearly 16,000 of its 2021

Medical leaders decry Supreme Court decision on affirmative action

DeSantis talks Trump, trans issues and 'what wokeness is'

Malaria cases in Florida and Texas: Here’s what you need to know

CDC wastewater surveillance dashboard to track bird flu hotspots

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Continuity nursing helped my family in our darkest PICU moments

Ending racial health disparities hinges on penalties, political will

focus

How to improve immunocompromised access to mAb treatments

DeSantis talks Trump, trans issues and 'what wokeness is'

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Making AI in medicine accessible to smaller, and rural hospitals

Affordable Connectivity Program vital to health care, experts say

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

entertainment

leisure time

Wikipedia

knowledge